Comparison of Cognitive-behaviour Therapy with Psychoanalytic and Psychodynamic Therapy for Depressed Patients - a Three-year Follow-up Study
Overview
Affiliations
Objective: The study investigates the effectiveness of long-term psychotherapies. Cognitive-behaviour therapy was compared with psychoanalytic and psychodynamic therapy in the treatment of patients with a primary diagnosis of unipolar depression.
Method: In a prospective, quasi-experimental design 100 patients were compared at pre- and post-treatment and three-year follow-up. Outcome measures were the Beck Depression Inventory and Global Severity Index for measuring symptoms, the Inventory of Interpersonal Problems and the Social Support Questionnaire for measurement of social-interpersonal functioning, and the INTREX Introject Questionnaire for measuring personality structure. Comparative effectiveness of the experimental groups was analyzed using mixed models.
Results: We found significant outcome differences between psychoanalytic therapy and cognitive-behaviour therapy in depressive and global psychiatric symptoms, partly social-interpersonal and personality structure at three-year follow-up. Psychodynamic therapy was superior to cognitive-behaviour therapy in the reduction of interpersonal problems.
Conclusion: Psychoanalytic therapy shows significantly longer-lasting effects compared to cognitive-behaviour therapy three years after termination of treatment, which is discussed as a dose-effect.
Malkomsen A, Wilberg T, Bull-Hansen B, Dammen T, Evensen J, Hummelen B BMC Psychiatry. 2025; 25(1):113.
PMID: 39934737 PMC: 11817821. DOI: 10.1186/s12888-025-06544-6.
Psychodynamically Informed Brain Stimulation: Building a Bridge from Brain to Mind.
Austelle C, Seery E Am J Psychoanal. 2024; 84(2):285-310.
PMID: 38871924 DOI: 10.1057/s11231-024-09444-y.
Ambresin G, Leuzinger-Bohleber M, Fischmann T, Axmacher N, Hattingen E, Bansal R BMC Psychiatry. 2023; 23(1):844.
PMID: 37974088 PMC: 10652457. DOI: 10.1186/s12888-023-05287-6.
Krakau L, Leuzinger-Bohleber M, Brahler E, Schmidt P, Rost F, Huber D BMJ Open. 2023; 13(7):e069332.
PMID: 37474167 PMC: 10357799. DOI: 10.1136/bmjopen-2022-069332.
Cera N, Monteiro J, Esposito R, Di Francesco G, Cordes D, Caldwell J Front Hum Neurosci. 2023; 16:1029256.
PMID: 36644207 PMC: 9832372. DOI: 10.3389/fnhum.2022.1029256.